Kinetics of cytokine expression during primary human immunodeficiency virus type 1 infection
about
Contribution of immune activation to the pathogenesis and transmission of human immunodeficiency virus type 1 infectionInfection of semen-producing organs by SIV during the acute and chronic stages of the diseaseElevations in IL-10, TNF-alpha, and IFN-gamma from the earliest point of HIV Type 1 infectionSerum levels of interleukin 6 in recently hospitalized tick-borne encephalitis patients correlate with age, but not with disease outcomeInduction of a Striking Systemic Cytokine Cascade prior to Peak Viremia in Acute Human Immunodeficiency Virus Type 1 Infection, in Contrast to More Modest and Delayed Responses in Acute Hepatitis B and C Virus InfectionsEpidemiology and interactions of Human Immunodeficiency Virus – 1 and Schistosoma mansoni in sub-Saharan AfricaThe cytokine network of acute HIV infection: a promising target for vaccines and therapy to reduce viral set-point?Nitric oxide synthesis enhances human immunodeficiency virus replication in primary human macrophagesAntiinflammatory profiles during primary SIV infection in African green monkeys are associated with protection against AIDS.Evaluation of a quantitative real-time PCR assay to measure HIV-specific mucosal CD8+ T cell responses in the cervix.Infection with human immunodeficiency virus type 1 upregulates DNA methyltransferase, resulting in de novo methylation of the gamma interferon (IFN-gamma) promoter and subsequent downregulation of IFN-gamma production.Displacement of SATB1-bound histone deacetylase 1 corepressor by the human immunodeficiency virus type 1 transactivator induces expression of interleukin-2 and its receptor in T cells.Surfactant protein D inhibits HIV-1 infection of target cells via interference with gp120-CD4 interaction and modulates pro-inflammatory cytokine production.Triggering TLR2, -3, -4, -5, and -8 reinforces the restrictive nature of M1- and M2-polarized macrophages to HIV.Molecular pathways in virus-induced cytokine production.Dynamic analysis of Th1/Th2 cytokine concentration during antiretroviral therapy of HIV-1/HCV co-infected patients.T Cell Activation and Cytokine Profile of Tuberculosis and HIV-Positive Individuals during Antituberculous Treatment and Efavirenz-Based Regimens.Reduced type 1 and type 2 cytokines in antiviral memory T helper function among women coinfected with HIV and HCV.Prostaglandin E2 reduces the release and infectivity of new cell-free virions and cell-to-cell HIV-1 transfer.Dissecting the role of dendritic cells in simian immunodeficiency virus infection and AIDSTLR2 activation enhances HIV nuclear import and infection through T cell activation-independent and -dependent pathwaysEarly cytokine and chemokine gene expression in lymph nodes of macaques infected with simian immunodeficiency virus is predictive of disease outcome and vaccine efficacy.Soluble mediators of inflammation in HIV and their implications for therapeutics and vaccine developmentMicrobial translocation, the innate cytokine response, and HIV-1 disease progression in Africa.Rapid influx and death of plasmacytoid dendritic cells in lymph nodes mediate depletion in acute simian immunodeficiency virus infection.Innate immune responses in primary HIV-1 infection.Initiation of antiretroviral therapy before detection of colonic infiltration by HIV reduces viral reservoirs, inflammation and immune activation.Electro-Magnetic Nano-Particle Bound Beclin1 siRNA Crosses the Blood-Brain Barrier to Attenuate the Inflammatory Effects of HIV-1 Infection in Vitro.Roles of autophagy in HIV infection.The development of therapeutic monoclonal antibodies: overview of the nonclinical safety assessment.Host factors in the pathogenesis of HIV disease.T-bet-expressing B cells during HIV and HCV infections.Cytokine response in multiple lymphoid tissues during the primary phase of feline immunodeficiency virus infection.Diverse host responses and outcomes following simian immunodeficiency virus SIVmac239 infection in sooty mangabeys and rhesus macaques.Human immunodeficiency virus type 1 Tat protein inhibits the SIRT1 deacetylase and induces T cell hyperactivationConstruction and in vitro properties of chimeric simian and human immunodeficiency virus with the human TNF-alpha gene.Interferon-inducible protein 10 (IP-10) is associated with viremia of early HIV-1 infection in Korean patients.IL-15 treatment during acute simian immunodeficiency virus (SIV) infection increases viral set point and accelerates disease progression despite the induction of stronger SIV-specific CD8+ T cell responses.Interleukin 18 and human immunodeficiency virus type I infection in adolescents and adults.Lipopolysaccharide suppresses HIV-1 replication in human monocytes by protein kinase C-dependent heme oxygenase-1 induction.
P2860
Q24550678-6414ED68-E792-41C7-AB7B-D5B01AF1AB95Q27301766-8BE6F114-04D4-4F41-8A23-7FEAE2FFA5AFQ27486378-99930325-736E-41F7-82AD-72791A882C0BQ27486417-48B2F0CE-7C18-4E22-BC64-71611777157AQ27488278-1AA23A2E-D8B5-4924-A8A8-5C4D9F92A9CBQ27499293-A256DB3F-F4A2-48D3-A2F8-094914BCF02DQ30406147-6AF368B1-AB42-41BE-A637-10085C5A65A8Q33604156-23E315DE-7020-4147-921F-58E938456307Q33709283-16E46B64-2E0A-4E95-8649-965C71D4C704Q33719485-A2B0ACAF-EB22-4424-A37C-2C71C27CE8DBQ33777676-77202D70-BFD5-4F4C-B9EE-93E1652CD581Q33860989-F9986464-1577-4F48-AB37-DCE116350515Q33921367-C4D2B35F-5E9A-4C78-8B39-B760CDA10970Q34059582-ADF29B8F-25B6-4111-B624-193D9A8C8653Q34174972-0885814B-CE74-427F-9CDA-075BD01EE584Q34245650-EF6837E6-CA20-4415-9EE8-8A59F822BA85Q34805000-C86B5A66-3F30-4AB5-B129-3503B1A59AE2Q35079621-9283BA0A-8900-43B8-BC1F-8E529F1EBCC7Q35105850-8320F27D-7CF3-43C1-BBC4-283FDB63C95AQ35118991-A414A59F-9C16-424D-9972-11DC17B1165AQ35685432-D013BB96-96D7-4ED3-AD8E-819247A7E7AAQ35876809-01BECF81-6E5C-4158-B77B-C287FCD2B0EBQ36162133-55DF6463-4C22-48BF-9269-B19CC2CB9F41Q37154019-37026B61-EAB4-478F-B402-6016AAC460EFQ37165164-638A98B4-E316-4EA1-A749-E3D994AE50F8Q37227226-4190EC26-8C12-4BE7-856A-BCA9D2E2717FQ37262786-03234E3F-BA8F-4B70-8827-7C11AF7115F6Q37590479-87627583-73C7-426B-B5F9-0E3A47A024CFQ38266749-3BFF6107-DA75-471E-938B-9E5B67492FF9Q38355263-648C9ACA-603F-4EE9-B121-5D58BCFF11B6Q38949921-4D326DE5-B35D-44B7-B53F-88C2A3119BEBQ39454938-AC32C46D-4026-4C69-8777-C64D97A41BADQ39582673-7B55CA3C-A378-4639-8E61-FC7999BA439AQ39582896-515F2EE9-BA9E-461A-BBF8-017B15639BDDQ40004324-F2A31D84-BAE1-42E1-83BE-4CB5BE107180Q40669188-28103FC7-363B-450E-BF15-42BFB81BB326Q41485531-6C01754E-F255-4F18-B6FD-5E9C97EB6783Q42453465-5CF25E71-11BB-4479-A58F-907314AE8FF9Q44129441-65C39D2A-D020-4782-AF05-FA6850AF8DF5Q53349420-4DD37EAE-4B70-45DB-B8D2-1203195A6F51
P2860
Kinetics of cytokine expression during primary human immunodeficiency virus type 1 infection
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 1996
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Kinetics of cytokine expressio ...... iciency virus type 1 infection
@en
Kinetics of cytokine expressio ...... ciency virus type 1 infection.
@nl
type
label
Kinetics of cytokine expressio ...... iciency virus type 1 infection
@en
Kinetics of cytokine expressio ...... ciency virus type 1 infection.
@nl
prefLabel
Kinetics of cytokine expressio ...... iciency virus type 1 infection
@en
Kinetics of cytokine expressio ...... ciency virus type 1 infection.
@nl
P2093
P2860
P356
P1476
Kinetics of cytokine expressio ...... iciency virus type 1 infection
@en
P2093
Demarest JF
Graziosi C
Vaccarezza M
P2860
P304
P356
10.1073/PNAS.93.9.4386
P407
P577
1996-04-01T00:00:00Z